L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
Recruiting · NCT05934318 · Registry updated 2025-06-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Infections, Mosquito-Borne Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Premature Birth, Urogenital Diseases, fetal growth restriction, hereditary endocrine growth disease, malaria, parasitic infectious disease, pregnancy disorder, protozoa infectious disease, vector-borne disease | Recruiting | Not applicable | 2025-06-27 | NCT05934318 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kenya Medical Research Institute | 33 |
| Liverpool School of Tropical Medicine | 30 |
| Telethon Kids Institute | 10 |
| University of Toronto | 140 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| KEMRI Centre for Global Health Research | Kisumu | Kenya | 1 |